CHINAGREEN BIO: The company has not yet started research and development in the field of synthetic biologyZhitong·Oct 28, 2025 at 07:55 PM300970-1.87%
CHINAGREEN BIO released its performance for the first three quarters, with a net profit attributable to the parent company of 16.3335 million yuan, an increase of 146.55%Zhitong·Oct 23, 2025 at 06:59 AM300970-1.87%
CHINAGREEN BIO plans to implement technological transformation on the original enoki mushroom production line at the fourth factory of its production base in Siyang, JiangsuZhitong·May 23, 2025 at 07:41 AM300970-1.87%
CHINAGREEN BIO released its first-quarter performance, with a net profit attributable to the parent company of 1.5447 million yuan, a year-on-year decrease of 11.2%Zhitong·Apr 23, 2025 at 11:35 AM300970-1.87%
CHINAGREEN BIO: GaoTou Development has cumulatively reduced its holdings by 1.04% of the company's sharesZhitong·Feb 20, 2025 at 03:35 AM300970-1.87%
CHINAGREEN BIO issues a profit warning, expecting a net loss of 38 million to 56 million yuan for the fiscal year 2024Zhitong·Jan 24, 2025 at 04:08 AM300970-1.87%
